{
  "input": {
    "mode": "execute_actions",
    "query": {
      "entity": "Familial tumour syndromes of the central and peripheral nervous system",
      "relation": "contraindication"
    },
    "items": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "与家族肿瘤综合症的潜在禁忌关系",
            "expectation": "明确标识任何潜在的安全风险，并评估与癌症药物的相容性",
            "assignee": "Skeptic"
          }
        ]
      },
      {
        "hypothesis_id": "H2",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "家族肿瘤综合症患者的具体安全风险",
            "expectation": "评估申请的药物对该患者群体的适用性与安全性",
            "assignee": "Skeptic"
          }
        ]
      },
      {
        "hypothesis_id": "H3",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "针对家庭肿瘤综合症的安全性分析",
            "expectation": "识别可能的药物-病症禁忌",
            "assignee": "Skeptic"
          }
        ]
      }
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "n_doxorubicin",
          "type": "Drug",
          "label": "Doxorubicin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_vincristine",
          "type": "Drug",
          "label": "Vincristine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_cyclophosphamide",
          "type": "Drug",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_temozolomide",
          "type": "Drug",
          "label": "Temozolomide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_etoposide",
          "type": "Drug",
          "label": "Etoposide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_bevacizumab",
          "type": "Drug",
          "label": "Bevacizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_methylprednisolone",
          "type": "Drug",
          "label": "Methylprednisolone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_olaparib",
          "type": "Drug",
          "label": "Olaparib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_lapatinib",
          "type": "Drug",
          "label": "Lapatinib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_dasatinib",
          "type": "Drug",
          "label": "Dasatinib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pegaspargase",
          "type": "Drug",
          "label": "Pegaspargase",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_sulfonamides",
          "type": "Drug",
          "label": "Sulfonamides",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target",
          "type": "Target",
          "label": "Target",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pathway",
          "type": "Pathway",
          "label": "Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_disease",
          "type": "Disease",
          "label": "Familial tumour syndromes of the central and peripheral nervous system",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "edges": [
        {
          "source": "n_doxorubicin",
          "target": "n_target",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "与癌症治疗相关的作用机制"
        },
        {
          "source": "n_vincristine",
          "target": "n_target",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "与癌症治疗相关的作用机制"
        },
        {
          "source": "n_cyclophosphamide",
          "target": "n_target",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "与癌症治疗相关的作用机制"
        },
        {
          "source": "n_temozolomide",
          "target": "n_target",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "与癌症治疗相关的作用机制"
        },
        {
          "source": "n_etoposide",
          "target": "n_target",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "与癌症治疗相关的作用机制"
        },
        {
          "source": "n_bevacizumab",
          "target": "n_target",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "与癌症治疗相关的作用机制"
        },
        {
          "source": "n_methylprednisolone",
          "target": "n_target",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "使用于癌症相关症状的治疗"
        },
        {
          "source": "n_olaparib",
          "target": "n_target",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "与癌症治疗相关的作用机制"
        },
        {
          "source": "n_lapatinib",
          "target": "n_target",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "用于特定类型癌症的靶向治疗"
        },
        {
          "source": "n_dasatinib",
          "target": "n_target",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "用于癌症特定途径"
        },
        {
          "source": "n_pegaspargase",
          "target": "n_target",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "癌症治疗中的应用"
        },
        {
          "source": "n_sulfonamides",
          "target": "n_target",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "与癌症治疗相关的作用机制"
        },
        {
          "source": "n_target",
          "target": "n_pathway",
          "relation": "involved_in",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "靶点与通路的直接关联"
        },
        {
          "source": "n_pathway",
          "target": "n_disease",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "病理机制与疾病的直接联系"
        }
      ],
      "round_index": 4
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates_per_hypothesis": []
  }
}